Alvotech (ALVO) Net Cash Flow (2021 - 2026)
Alvotech's (ALVO) quarterly Net Cash Flow came in at $78.8 million in Q2 2026, down 28.53% on a YoY basis from $110.3 million in Q2 2025, and up 173.26% quarter-over-quarter from -$107.6 million in Q1 2026.
Analysis
Alvotech (ALVO) Net Cash Flow (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Net Cash Flow for 6 consecutive years, with $78.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Cash Flow fell 28.53% year-over-year to $78.8 million; the trailing twelve-month figure through Jun 2026 stood at -$9.0 million (up 81.3% YoY), and the FY2025 full-year result was $116.4 million, up 179.89% from the prior year.
- Net Cash Flow improved to $78.8 million in Q2 2026 per ALVO's latest filing, from -$107.6 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $338.4 million in Q4 2025 and bottomed at -$375.9 million in Q4 2022.
- Historically, Net Cash Flow has averaged -$66.4 million across 5 years, with a median of -$54.8 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Net Cash Flow jumped 305.44% in 2025, then plunged 686.2% in 2026.
- Over 5 years, Net Cash Flow stood at -$375.9 million in 2022, then gained by 10.12% to -$337.9 million in 2023, then gained by 25.59% to -$251.4 million in 2024, then soared by 234.62% to $338.4 million in 2025, then sank by 76.71% to $78.8 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $78.8 million, -$107.6 million, and $338.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -81.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -912.40 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -44.45 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | -64.63 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 528.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 78.82 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 48.97 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 52.66 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.82 Mn |
| Mar 31, 2026 | -107.59 Mn |
| Dec 31, 2025 | 338.45 Mn |
| Sep 30, 2025 | -318.63 Mn |
| Jun 30, 2025 | 110.29 Mn |
| Mar 31, 2025 | -13.69 Mn |
| Dec 31, 2024 | -251.42 Mn |
| Sep 30, 2024 | 106.94 Mn |
| Jun 30, 2024 | -53.68 Mn |
| Mar 31, 2024 | 54.30 Mn |
| Dec 31, 2023 | -337.86 Mn |
| Jun 30, 2023 | -55.95 Mn |
| Dec 31, 2022 | -375.93 Mn |
| Jun 30, 2022 | -103.57 Mn |
| Dec 31, 2021 | -70.76 Mn |
| Sep 30, 2021 | -72.68 Mn |